/
TXG
$80.70+$1.60 (+2.02%)live
Change$-77.83
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$10.3B
130M shares
52-week range
$11.16 – $82.68
97% from low
Sector
LABORATORY ANALYTICAL INSTRUMENTS
Exchange
NASDAQ
CS
P/S (TTM)
17.0
EV / FCF (TTM)
82.9
10x Genomics, Inc. Class A Common Stock
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
www.10xgenomics.com- Employees
- 1,178
- IPO / List date
- Sep 12, 2019
- HQ
- PLEASANTON, CA
Held by traders on TradeandTell
No one on the platform currently holds TXG.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 1,008,739 | $21.4M |
| Bridgewater Associatesas of 2026-03-31 | 35,101 | $745.2K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded TXG yet.
